C. elegans : a prominent platform for modeling and drug screening in neurological disorders.
Stefano RomussiSebastián GiuntiNatalia AndersenMaría José De Rosa
Published in: Expert opinion on drug discovery (2024)
as a platform to replicate nervous system pathologies and conduct high-throughput automated assays in the initial phases of drug discovery is pivotal for rendering therapeutic options more attainable and cost-effective.